Brief: Anavex Life Sciences Reports Fiscal 2023 Second Quarter Financial Results
09/05/2023 13:36
May 9 (Reuters) - Anavex Life Sciences Corp AVXL.O :
* ANAVEX LIFE SCIENCES REPORTS FISCAL 2023 SECOND QUARTER
FINANCIAL RESULTS
* ANAVEX LIFE SCIENCES - ON TRACK TO RELEASE TOP-LINE DATA
OF
POTENTIALLY PIVOTAL ANAVEX®2-73-RS-003 PHASE 2/3 EXCELLENCE
PEDIATRIC CLINICAL TRIAL IN H2
* ANAVEX LIFE SCIENCES CORP - QTRLY LOSS PER SHARE $0.17
Source text for Eikon: ID:nGNX6sPdxF
Further company coverage: AVXL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Anavex Life Sciences
See all newsBrief: Anavex Provides Corporate Update, Announces Completion Of Clinical Conduct Of Adme And Ddi Clinical Studies
Brief: Anavex Receives FDA Clearance Of Its Ind Application For Blarcamesine In Fragile X Syndrome
Brief: Glass Lewis Recommends Anavex Stockholders To Vote For PVG’s Director Nominees
Brief: PVG Calls For Replacing Anavex Board, Hiring "Experienced" CEO
Brief: Pvg Asset Management- Nominates Six Director Candidates For Anavex Board